Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06622187
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-09-03
Brief Title:
Use of Desmopressin Prior to Graft Kidney Biopsy in Patients with High Risk of Bleeding
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Use of Desmopressin Prior to Graft Kidney Biopsy in Patients with High Risk of Bleeding a Randomized Clinical Trial
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to evaluate the efficacy and safety of desmopressin to prevent bleeding after percutaneous renal graft biopsy in patients at high risk of bleeding
Researchers will compare desmopressin DDAVP to placebo to see if the drug reduces the risk of bleeding events related to kidney biopsy
Participants will receive intravenous desmopressin medication 100ml or placebo 100mL of saline solution before the kidney biopsy
Researchers will compare desmopressin DDAVP to placebo to see if the drug reduces the risk of bleeding events related to kidney biopsy
Participants will receive intravenous desmopressin medication 100ml or placebo 100mL of saline solution before the kidney biopsy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None